GERN – Geron Corporation
Geron CorporationGERN
$1.37Name : Geron Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $874,546,688.00
EPSttm : -0.12
Geron Corporation
$1.37
0.00%$0.00000000000000Float Short %
12.52
Margin Of Safety %
Put/Call OI Ratio
0.23
EPS Next Q Diff
EPS Last/This Y
0.15
EPS This/Next Y
0.1
Price
1.37
Target Price
3.6
Analyst Recom
2
Performance Q
-0.72
Relative Volume
1.15
Beta
0.62
Ticker: GERN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-10 | GERN | 1.295 | 0.21 | 0.00 | 114576 |
| 2025-12-11 | GERN | 1.38 | 0.21 | 0.01 | 114526 |
| 2025-12-12 | GERN | 1.36 | 0.21 | 0.21 | 114603 |
| 2025-12-15 | GERN | 1.335 | 0.21 | 0.18 | 114597 |
| 2025-12-16 | GERN | 1.34 | 0.21 | 0.24 | 115419 |
| 2025-12-17 | GERN | 1.405 | 0.21 | 0.17 | 115754 |
| 2025-12-18 | GERN | 1.345 | 0.21 | 0.45 | 116419 |
| 2025-12-19 | GERN | 1.32 | 0.21 | 0.02 | 116505 |
| 2025-12-22 | GERN | 1.345 | 0.21 | 0.02 | 109443 |
| 2025-12-23 | GERN | 1.335 | 0.21 | 0.26 | 110279 |
| 2025-12-26 | GERN | 1.365 | 0.22 | 0.19 | 111701 |
| 2025-12-29 | GERN | 1.365 | 0.22 | 0.02 | 112133 |
| 2025-12-30 | GERN | 1.335 | 0.22 | 0.39 | 112409 |
| 2025-12-31 | GERN | 1.325 | 0.22 | 0.03 | 112450 |
| 2026-01-02 | GERN | 1.325 | 0.22 | 0.45 | 112472 |
| 2026-01-05 | GERN | 1.315 | 0.23 | 0.00 | 113388 |
| 2026-01-06 | GERN | 1.31 | 0.23 | 0.00 | 113430 |
| 2026-01-07 | GERN | 1.365 | 0.23 | 0.04 | 114281 |
| 2026-01-08 | GERN | 1.365 | 0.23 | 0.01 | 114537 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-10 | GERN | 1.23 | 1.7 | -20.7 | -0.12 |
| 2025-12-11 | GERN | 1.39 | 1.7 | -22.0 | -0.12 |
| 2025-12-12 | GERN | 1.36 | 1.7 | -13.9 | -0.12 |
| 2025-12-15 | GERN | 1.33 | 1.7 | 54.6 | -0.12 |
| 2025-12-16 | GERN | 1.33 | 1.7 | 54.8 | -0.12 |
| 2025-12-17 | GERN | 1.40 | 1.7 | 55.5 | -0.12 |
| 2025-12-18 | GERN | 1.35 | 1.7 | 54.5 | -0.12 |
| 2025-12-19 | GERN | 1.32 | 1.7 | 54.7 | -0.12 |
| 2025-12-22 | GERN | 1.36 | 1.7 | 55.2 | -0.12 |
| 2025-12-23 | GERN | 1.34 | 1.7 | 54.8 | -0.12 |
| 2025-12-26 | GERN | 1.37 | 1.7 | 54.6 | -0.12 |
| 2025-12-29 | GERN | 1.37 | 1.7 | 54.9 | -0.12 |
| 2025-12-30 | GERN | 1.34 | 1.7 | 54.6 | -0.12 |
| 2025-12-31 | GERN | 1.33 | 1.7 | 54.8 | -0.12 |
| 2026-01-02 | GERN | 1.33 | 1.7 | 55.0 | -0.12 |
| 2026-01-05 | GERN | 1.31 | 1.7 | 54.8 | -0.12 |
| 2026-01-06 | GERN | 1.32 | 1.7 | 54.9 | -0.12 |
| 2026-01-07 | GERN | 1.37 | 1.7 | 55.4 | -0.12 |
| 2026-01-08 | GERN | 1.37 | 1.7 | 54.9 | -0.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-10 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-11 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-12 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-15 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-16 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-17 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-18 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-19 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-22 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-23 | GERN | 0.00 | -1.06 | 12.74 |
| 2025-12-26 | GERN | 0.00 | -1.06 | 12.52 |
| 2025-12-29 | GERN | 0.00 | -1.09 | 12.52 |
| 2025-12-30 | GERN | 0.00 | -1.09 | 12.52 |
| 2025-12-31 | GERN | 0.00 | -1.09 | 12.52 |
| 2026-01-02 | GERN | 0.00 | -1.09 | 12.52 |
| 2026-01-05 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-06 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-07 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-08 | GERN | 0.00 | -1.08 | 12.52 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.03
Avg. EPS Est. Current Quarter
-0.04
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
Institutional Transactions
-1.08
Beta
0.62
Average Sales Estimate Current Quarter
50
Average Sales Estimate Next Quarter
53
Fair Value
Quality Score
47
Growth Score
56
Sentiment Score
33
Actual DrawDown %
74.4
Max Drawdown 5-Year %
-79
Target Price
3.6
P/E
Forward P/E
PEG
P/S
4.77
P/B
3.52
P/Free Cash Flow
EPS
-0.12
Average EPS Est. Cur. Y
-0.12
EPS Next Y. (Est.)
-0.02
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-43.61
Relative Volume
1.15
Return on Equity vs Sector %
-59.5
Return on Equity vs Industry %
-44.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
54.9
Geron CorporationSector: Healthcare
Industry: Biotechnology
Employees: 229
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading